Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Hydroxocobalamin | hsa00190 | Oxidative phosphorylation | 3.27E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Hydroxocobalamin | hsa00280 | Valine, leucine and isoleucine degradation | 2.75E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Hydroxocobalamin | hsa01100 | Metabolic pathways | 1.66E-02 | 31 | Q9Y234, O14521, P15144, Q99707, P11310, P27707, Q13370, P36959, Q13956, P22748, P55809, P06280, P30043, Q02252, O60701, O14772, O95954, Q9HCC0, P33121, P04406, Q96EB6, O15466, P36551, Q9BX95, P09960, Q9P2R7, Q9UHY7, P35573, Q13488, Q16718, Q02809 | LIPT1, SDHD, ANPEP, MTR, ACADM, DCK, PDE3B, GMPR, PDE6H, CA4, OXCT1, GLA, BLVRB, ALDH6A1, UGDH, FPGT, FTCD, MCCC2, ACSL1, GAPDH, SIRT1, ST8SIA5, CPOX, SGPP1, LTA4H, SUCLA2, ENOPH1, AGL, TCIRG1, NDUFA5, PLOD1 | More | | Hydroxocobalamin | hsa03013 | RNA transport | 3.46E-03 | 11 | O14980, P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, Q14240, Q9Y6A5 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, EIF4A2, TACC3 | More | | Hydroxocobalamin | hsa03018 | RNA degradation | 2.97E-02 | 2 | Q9Y2L1, Q8IU60 | DIS3, DCP2 | More | | Hydroxocobalamin | hsa03450 | Non-homologous end-joining | 3.15E-02 | 1 | P13010 | XRCC5 | More | | Hydroxocobalamin | hsa04064 | NF-kappa B signaling pathway | 1.86E-02 | 9 | P10415, O00463, P01375, Q04759, Q13077, Q16548, P06239, P24522, P09341 | BCL2, TRAF5, TNF, PRKCQ, TRAF1, BCL2A1, LCK, GADD45A, CXCL1 | More | | Hydroxocobalamin | hsa04071 | Sphingolipid signaling pathway | 2.52E-03 | 7 | P17252, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | PRKCA, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Hydroxocobalamin | hsa04114 | Oocyte meiosis | 3.60E-02 | 6 | O95067, Q9UJX2, Q14643, P22694, Q16539, Q13362 | CCNB2, CDC23, ITPR1, PRKACB, MAPK14, PPP2R5C | More | | Hydroxocobalamin | hsa04140 | Autophagy - animal | 3.50E-02 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Hydroxocobalamin | hsa04145 | Phagosome | 4.84E-05 | 11 | O75015, Q15075, Q15080, P14598, Q13509, Q13488, P05164, P78380, O60603, P35443, P13765 | FCGR3B, EEA1, NCF4, NCF1, TUBB3, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Hydroxocobalamin | hsa04217 | Necroptosis | 1.32E-02 | 5 | P01568, P07384, Q6FI13, P10415, O43633 | IFNA21, CAPN1, H2AC18; H2AC19, BCL2, CHMP2A | More | | Hydroxocobalamin | hsa04540 | Gap junction | 1.78E-02 | 3 | P17252, Q13509, Q14643 | PRKCA, TUBB3, ITPR1 | More | | Hydroxocobalamin | hsa04612 | Antigen processing and presentation | 7.10E-03 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Hydroxocobalamin | hsa04613 | Neutrophil extracellular trap formation | 1.85E-02 | 12 | O60603, P05164, P08246, Q9UM07, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Hydroxocobalamin | hsa04621 | NOD-like receptor signaling pathway | 1.75E-02 | 10 | Q16539, Q14643, P10599, Q9H1Y0, P43490, O00463, P10415, P01375, P09341, P12838 | MAPK14, ITPR1, TXN, ATG5, PBEF1, TRAF5, BCL2, TNF, CXCL1, DEFA4 | More | | Hydroxocobalamin | hsa04630 | JAK-STAT signaling pathway | 4.27E-02 | 4 | P10415, P40189, Q9UHF4, P01568 | BCL2, IL6ST, IL20RA, IFNA21 | More | | Hydroxocobalamin | hsa04640 | Hematopoietic cell lineage | 3.29E-02 | 8 | P13612, P27930, P15144, P25063, P09693, P01732, P13765, P01375 | ITGA4, IL1R2, ANPEP, CD24, CD3G, CD8A, HLA-DOB, TNF | More | | Hydroxocobalamin | hsa04650 | Natural killer cell mediated cytotoxicity | 7.61E-03 | 9 | P01375, P06239, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, LCK, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Hydroxocobalamin | hsa04657 | IL-17 signaling pathway | 4.82E-02 | 6 | O00463, Q16539, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, CXCL1, MMP9, LCN2, TNF | More | | Hydroxocobalamin | hsa04658 | Th1 and Th2 cell differentiation | 5.60E-04 | 9 | Q04759, P20963, P09693, Q16539, P06239, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, MAPK14, LCK, STAT4, GATA3, TBX21, HLA-DOB | More | | Hydroxocobalamin | hsa04659 | Th17 cell differentiation | 1.42E-02 | 8 | Q04759, Q16539, P06239, P13765, Q9UL17, P23771, P09693, P20963 | PRKCQ, MAPK14, LCK, HLA-DOB, TBX21, GATA3, CD3G, CD247 | More | | Hydroxocobalamin | hsa04660 | T cell receptor signaling pathway | 2.83E-03 | 10 | P01375, Q04759, O95267, Q08881, P20963, P09693, P01732, Q13191, P06239, Q16539 | TNF, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, LCK, MAPK14 | More | | Hydroxocobalamin | hsa04666 | Fc gamma R-mediated phagocytosis | 2.35E-02 | 3 | P23528, P14598, P17252 | CFL1, NCF1, PRKCA | More | | Hydroxocobalamin | hsa04668 | TNF signaling pathway | 2.63E-02 | 7 | P01375, O00463, Q16539, P09341, P20749, Q13077, P14780 | TNF, TRAF5, MAPK14, CXCL1, BCL3, TRAF1, MMP9 | More | | Hydroxocobalamin | hsa04725 | Cholinergic synapse | 2.35E-02 | 3 | Q14643, P17252, P10415 | ITPR1, PRKCA, BCL2 | More | | Hydroxocobalamin | hsa04726 | Serotonergic synapse | 4.57E-02 | 3 | Q14643, P17252, P33260 | ITPR1, PRKCA, CYP2C18 | More | | Hydroxocobalamin | hsa04730 | Long-term depression | 1.94E-02 | 2 | P17252, Q14643 | PRKCA, ITPR1 | More | | Hydroxocobalamin | hsa04918 | Thyroid hormone synthesis | 4.49E-02 | 2 | P17252, Q14643 | PRKCA, ITPR1 | More | | Hydroxocobalamin | hsa04922 | Glucagon signaling pathway | 3.74E-02 | 3 | Q12778, Q13370, Q14643 | FOXO1, PDE3B, ITPR1 | More | | Hydroxocobalamin | hsa04924 | Renin secretion | 3.11E-02 | 2 | Q14643, Q13370 | ITPR1, PDE3B | More | | Hydroxocobalamin | hsa04928 | Parathyroid hormone synthesis, secretion and action | 5.37E-03 | 4 | Q14643, P17252, P10415, Q9UEF7 | ITPR1, PRKCA, BCL2, KL | More | | Hydroxocobalamin | hsa04929 | GnRH secretion | 3.11E-02 | 2 | Q14643, P17252 | ITPR1, PRKCA | More | | Hydroxocobalamin | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 3.11E-02 | 2 | Q9UEF7, P17252 | KL, PRKCA | More | | Hydroxocobalamin | hsa04972 | Pancreatic secretion | 3.11E-02 | 2 | Q14643, P17252 | ITPR1, PRKCA | More | | Hydroxocobalamin | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.66E-02 | 6 | Q14643, Q13509, P10415, P17252, P07384, P04628 | ITPR1, TUBB3, BCL2, PRKCA, CAPN1, WNT1 | More | | Hydroxocobalamin | hsa05110 | Vibrio cholerae infection | 4.49E-02 | 2 | Q13488, P17252 | TCIRG1, PRKCA | More | | Hydroxocobalamin | hsa05140 | Leishmaniasis | 6.04E-03 | 7 | P13612, O75015, P13765, O60603, P01375, Q16539, Q15080 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, MAPK14, NCF4 | More | | Hydroxocobalamin | hsa05144 | Malaria | 4.68E-02 | 4 | O60603, P01375, P35443, P26718 | TLR2, TNF, THBS4, KLRK1 | More | | Hydroxocobalamin | hsa05146 | Amoebiasis | 1.36E-02 | 7 | P09341, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Hydroxocobalamin | hsa05150 | Staphylococcus aureus infection | 4.94E-02 | 5 | P21730, P21462, O75015, P13765, P12838 | C5AR1, FPR1, FCGR3B, HLA-DOB, DEFA4 | More | | Hydroxocobalamin | hsa05152 | Tuberculosis | 7.48E-03 | 5 | Q13488, O60603, P10415, P01568, Q9UDY8 | TCIRG1, TLR2, BCL2, IFNA21, MALT1 | More | | Hydroxocobalamin | hsa05170 | Human immunodeficiency virus 1 infection | 9.30E-04 | 14 | P01375, P17252, O00463, Q14643, P01568, Q16539, O60603, O95067, P23528, P09693, P20963, P10415, Q93034, Q9Y6Q5 | TNF, PRKCA, TRAF5, ITPR1, IFNA21, MAPK14, TLR2, CCNB2, CFL1, CD3G, CD247, BCL2, CUL5, AP1M2 | More | | Hydroxocobalamin | hsa05202 | Transcriptional misregulation in cancer | 1.36E-02 | 12 | P14780, P27930, Q15744, Q16548, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P41182, P24522 | MMP9, IL1R2, CEBPE, BCL2A1, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, GADD45A | More | | Hydroxocobalamin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.36E-02 | 7 | O95267, P20963, P09693, P06239, O60603, Q04759, Q16539 | RASGRP1, CD247, CD3G, LCK, TLR2, PRKCQ, MAPK14 | More | | Hydroxocobalamin | hsa05310 | Asthma | 1.59E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Hydroxocobalamin | hsa05320 | Autoimmune thyroid disease | 4.49E-02 | 2 | P01568, P10747 | IFNA21, CD28 | More | | Hydroxocobalamin | hsa05321 | Inflammatory bowel disease | 1.04E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Hydroxocobalamin | hsa05323 | Rheumatoid arthritis | 1.78E-02 | 3 | Q13488, P10747, O60603 | TCIRG1, CD28, TLR2 | More | | Hydroxocobalamin | hsa05332 | Graft-versus-host disease | 1.71E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | Hydroxocobalamin | hsa05418 | Fluid shear stress and atherosclerosis | 3.49E-02 | 7 | Q16539, Q14145, P10599, P14780, P01375, P10415, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, BCL2, IL1R2 | More | | |